EMCrit Podcast 133 – The First Prehospital REBOA

field-reboa

A few months ago, we spoke about REBOA-resuscitative endovascular balloon occlusion of the aorta. You might have thought to yourself, “Interesting, but I’ll never be doing that.” Well, not so fast, on today’s podcast we speak to the retrieval doctor that performed the first REBOA in the field.

REBOA in the Field and the ED

Gareth-Davies

In London, the idea of bringing REBOA to the field and the ED was made reality by Gareth Davies. Dr. Davies is Chair and Medical Director of the London Air Ambulance (London HEMS), one of the best HEMS services in the world. In the first part of the podcast, we hear how he conceptualized and enacted the plan to bring REBOA to the field.

REBOA Training at London HEMS (Attrib. Needed)

REBOA Training at London HEMS (Attrib. Needed)

The First Prehospital REBOA

JonnyPriceThen we speak with Jonny Price, Anesthesia and Intensive Care registrar doing a secondment in HEMS. At the time of the events of the podcast, he was flying with London HEMS. His story of the first prehospital REBOA is fascinating.

Special thanks to Cliff Reid for making these interviews possible.

EVO-Logo-on-White

SMACC Equipment Videos Online (EVO) Competition

Consider submitting a video and winning a free registration to SMACC Chicago. Go to the SMACC Site and Enter Now.

Now on to the podcast…

Play

Podcast 132 – MoTR – Toughness Part I with Michael Lauria

pj

Today, I interview Mike Lauria on the concepts of toughness and resilience.

The Rationale of Selection Courses/Indoc

80-90% Attrition for the PJs Indoc

One of the things that people, I think, find distasteful about selection programs in the civilian word is that it uncovers fundamental weaknesses and shortfalls.  This is no commentary on the intrinsic worth of the individual.  It doesn’t necessarily mean that they are smart or dumb.  But it is indicative of some inability or failure to meet a standard.  While it is hard for many civilians (and military members for that matter) to swallow, perhaps not everyone is cut out for a particular discipline.  Maybe we shouldn’t be forcing training, pushing people along, coddling individuals to maintain the outward appearance that a program is “successful” if an individual can’t make it through some sort of initial pipeline.  Perhaps a benefit of selection is making sure that the right people are there to begin with and the individuals that were simply not made for it are directed elsewhere.

I lost the source for the above quote, but I think it describes the process well. If anyone has it, please send me the attribution.

Builds an innate Espirit de Corps and a common thread of self and team-reliance

Residency as the Pipeline

Should we have culmination tests and exercises at the end of residency?

Stress Inoculation/Cognitive Tempering

Mike discusses four stages to do this right:

  1. Conceptualization-give a background of stress responses, why they happen, and what to expect.
  2. Train and educate on the skills and tasks we want to see performed under stress. Then give the tools to deal with the expected stress. The latter is where we may be failing our learners
  3. Do a dry run to train in simulation without added stressors
  4. Run the same training with stress inoculation

How can we make #4 work in EM/CCM?

Sound, distractions, equipment failures, and deliberate poor communications

So what tools can we offer for #2?

Mike offers an acronym: Beat The Stress, Fool

  • B is for Breathe. Breathe tactically. See the On Combat Podcast for a description (and there is an app for that too: Tactical Breather App)
  • T is for Talk. Self Talk. Positive self-talk is used by athletes and any elite performance group.
  • S is for See. Visualization. Visualize yourself performing the task exactly how you want to see it done.
  • F is for Focus. A key word to activate the state you want. Mike has chosen “focus” as his word. We then had a brief discussion of the book, the Art of Learning by Josh Waitzkin. The author creates an entire relaxation and mindset ritual that eventually gets boiled down to a key word or short set of actions. You’ll be hearing more about this book on the podcast.

When Mike asked if I had anything to add to this excellent set of tools, I discussed this TED Video by Dr. Amy Cuddy:

 

So maybe…Beat the Stress, Foolish Padawan with a P for posture??

Too Much Macho Militarization?

Mike posted a Youtube Video Addressing this question

Cliff Reid’s Resus.me Post on Self-Defense

During the intro, I discussed the contentious self-defense post on resus.me

Update

Some Anesthesia programs are already doing a modified interview process–thanks Lauren!

SNAG-0001

Here is the article: (non-tech-skills-interview-process)

Now on to the Podcast…

Play

EMCrit Podcast 131 – Cut to Air: Surgical Airway from SMACC Gold

machete

This is the resource page for all things Crics (Cricothyroidotomy)

We spoke a ton about cricothyrotomy way back in episode 24; this is an update

Understand the Surgically Inevitable Airway (thanks, Rich)

In appropriate circumstances (prophylactic cricothyroidotomy) has numerous advantages, not least the potential to secure and check the ‘rescue airway’ in a calm and unhurried manner, without hypoxia, before an emergency arises

— NAP4 Study

Anatomy

Use a Checklist so you are Ready!

CricCON2

Click for Full-Size

Click for Full-Size

Here was the original CricCON Wee

Which Trach Should you use?

Needle Cric

I don’t recommend this method, but some just will never feel comfortable cutting the neck

Cricothyrotomy Lecture Videos

Build a Cric Trainer

Here are My Slides

Now on to the Video…

EMCrit Podcast 130 – Hemodynamic-Directed Dosing of Epinephrine for Cardiac Arrest

epi-pen

Today on the podcast, I address the last little bit from my SMACC lecture on the new management of the intra-arrest: hemodynamic, individualized dosing of epinephrine.

normanparadisadonehThe podcast is interspersed with clips from Professor Norman Paradis

Articles/Posts on Epinephrine by ACLS Guidelines

  • (15306666),
  • http://www.emdocs.net/epinephrine-cardiac-arrest/
  • http://www.jems.com/article/patient-care/new-resuscitative-protocol
  • (24846323)
  • (19934423)

Epinephrine Dosing Based on DBP

Three Swine Study

(Crit Care Med. 2013 Dec;41(12):2698-704)

(Resuscitation. 2013 May;84(5):696-701)

(24945902)
Here is the abstract from the latter study:

AIM: Advances in cardiopulmonary resuscitation (CPR) have focused on the generation and maintenance of adequate myocardial blood flow to optimize the return of spontaneous circulation and survival. Much of the morbidity associated with cardiac arrest survivors can be attributed to global brain hypoxic ischemic injury. The objective of this study was to compare cerebral physiological variables using a hemodynamic directed resuscitation strategy versus an absolute depth-guided approach in a porcine model of ventricular fibrillation (VF) cardiac arrest.

METHODS: Intracranial pressure and brain tissue oxygen tension probes were placed in the frontal cortex prior to induction of VF in 21 female 3month old swine. After 7minutes of VF, animalswere randomized to receive one of three resuscitation strategies: 1) Hemodynamic Directed Care (CPP-20): chest compressions (CCs) with depth titrated to a target systolic blood pressure of 100mmHg and titration of vasopressors to maintain coronary perfusion pressure (CPP)> 20mmHg; 2) Depth 33mm(D33): target CC depth of 33mm with standard American Heart Association (AHA) epinephrine dosing; or 3) Depth 51mm(D51): target CC depth of 51mm with standard AHA epinephrine dosing.

RESULTS: Cerebral perfusion pressures (CerePP )were significantly higher in the CPP-20 group compared to both D33 (p<0.01) and D51 (P=0.046), and higher in survivors compared to non-survivors irrespective of treatment group (P<0.01).Brain tissue oxygen tension was also higher in the CPP-20 group compared to both D33 (P<0.01) and D51 (P=0.013), and higher in survivors compared to non-survivors irrespective of treatment group (P<0.01).Subjects with a CPP>20mm Hg were 2.7 times more likely to have a CerePP>30mm Hg (P< 0.001).

CONCLUSIONS: Hemodynamic directed resuscitation strategy targeting coronary perfusion pressure>20mmHg following VF arrest was associated with higher cerebral perfusion pressures and brain tissue oxygen tensions during CPR. University of Pennsylvania IACUC protocol #803026.

Human Study by Dr. Paradis

Coronary Perfusion Pressure and the Return of Spontaneous Circulation in Human Cardiopulmonary Resuscitation

(10.1001/jama.1990.03440080084029)

Coronary perfusion pressure (CPP), the aortic-to-right atrial pressure gradient during the relaxation phase of cardiopulmonary resuscitation, was measured in 100 patients with cardiac arrest. Coronary perfusion pressure and other variables were compared in patients with and without return of spontaneous circulation (ROSC). Twenty-four patients had ROSC. Initial CPP (mean±SD) was 1.6 ± 8.5 mm Hg in patients without ROSC and 13.4 ± 8.5 mm Hg in those with ROSC. The maximal CPP measured was 8.4 ±10.0 mm Hg in those without ROSC and 25.6 ±7.7 mm Hg in those with ROSC. Differences were also found for the maximal aortic relaxation pressure, the compression-phase aortic-to— right atrial gradient, and the arterial Po2. No patient with an initial CPP less than 0 mm Hg had ROSC. Only patients with maximal CPPs of 15 mm Hg or more had ROSC, and the fraction of patients with ROSC increased as the maximal CPP increased. A CPP above 15 mm Hg did not guarantee ROSC, however, as 18 patients whose CPPs were 15 mm Hg or greater did not resuscitate. Of variables measured, maximal CPP was most predictive of ROSC, and all CPP measurements were more predictive than was aortic pressure alone. The study substantiates animal data that indicate the importance of CPP during cardiopulmonary resuscitation.

Good Review on Epinephrine

Epi Review

AHA Cardiopulmonary Resuscitation Quality Statement

by Meaney P. et al (Circulation 2013;128:417)

Metrics

  • CCF>80%
  • Rate 100-120
  • 5cm depth
  • Full Recoil
  • <12 BPM, Minimal Chest Rise

Monitoring/Feedback

  • Art/CVP CPP>20
  • Just Art Line DBP>25-30 (I disagree)
  • ETCO2>20 mm Hg

If DBP < 20 optimize compressions or vasopressors (Circulation 2011;123:e236)

CVP can be higher during the poor flow of the arrest state (3970745),(Am J Emerg Med. 1985 Jan;3(1):11-4.), and (3946853) and this one had a mean of 16 (10.1161/01.CIR.80.2.361)

so I would shoot for 35-40 mm Hg

Goal is to give less epineprhine

Hemodynamic-directed CPR Review

(24783998)

Now on to the Podcast…

Play

Bibliography

MotR – Mike Lauria on “Making the Call”

Mind of the Resuscitationist Wee

MikeLauriaMike Lauria is the @resuspadawan. You’ll be hearing a lot more about Mike when he comes on the show for an interview. For now, know that he was Air Force Pararescue, now a medic on the Dartmouth-Hitchcock Advanced Response Team (DART), and will be starting medical school in the Fall. He has a special interest in cognitive decision making under stress, aka the Mind of the Resuscitationist.

Recognition Primed Decision Making (RPD)

Sources of Power by Gary Klein

OODA Loop

From 40-second Boyd. Read a summary on wikipedia

ooda-loop-small

Cognitive Unloading

  • Standardization & Preparation
  • Checklists
  • Premade Decision Points and Triggers

Cognitive Rally Points (Stop Points)

  • Hard and Soft Rally Points
  • Take a Deep Breath

Build Decision Making Power

  • Deliberate Practice
  • Review Experiences
  • Timely Expert Feedback
  • Socratic Method-Suck it Up!
  • Simulation

Stress Inoculation

  • Cognitive Tempering
  • The Rule of 130%-do the basics better than anyone else
  • Limbic Learning-emotional reaction burns it in
  • Train until you can’t get it wrong
  • You fall to the level of your training

Stay Flexible

  • Cognitive Flexibility
  • Acknowledge BIases
  • Ask disconfirming questions

The Slides

Now on to the Lecture…

Play

Podcast 129 – LAMW: The Neurocritical Care Intubation

head-explode

This is the another of the Laryngoscope as a Murder Weapon lectures; though in this case it is really more of an aggravated assault.

Who is this For?

Semi-elective intubations for patients with presumed or known elevated ICP

In TBI severity of brain injury doesn’t predict the lack of need for pharmacological blunting of increase in MAP or ICP (23511147)

The prototypical case requiring this treatment is a high-grade SAH prior to securing the aneurysm

This is the same way we would intubate an aortic dissection patient

Preoxygenation

Ap Ox and high-flow fiO2 for the full 3 minutes or longer

ETCO2

Put it on the BVM

Non-Pharmacologic Methods to Blunt Reflex Response

Limit time of laryngoscopy and atraumatic laryngoscopy

Leave the patient upright until the last possible moment, then intubate in 20 degrees head-up

No-touch intubation with video laryngoscopy by the best intubator

Pretreatment

Control the BP BEFORE the intubation

Lidocaine

While there is evidence that it blunts ICP rise and cough response, there is no good evidence that this has clinical results.(11696494) Literature is pretty good on endotracheal suctioning, but nothing on patient-important outcomes during intubation. Not hemodynamically active in this one study, but I have experienced radical drops in BP. (22633717)

Local is more effective than IV. (10861151)

Lidocaine References (11696494), (17358099), (23683444), (7772359),

Fentanyl

Dose 5 mcg/kg (6318605), (7032347)

All equipment meds must be prepared before administration. Someone must be watching the pt.

Remifentanil

Remifentanil can also be used, but I don’t have so I can’t speak about it

Esmolol

Dose 1.5-2 mg/kg ~ 3min beforehand

Combo of Esmolol and Fentanyl (1363221) (7788827) (9084524),(1672488)

Nicardipine

Dose 20 mcg/kg (average 1.4 mg)

(21696933) and (10553821) and Review Article (16978041)

Other Group’s Recs

At this stage, Emergency Airway Course only recommends Lidocaine and Fentanyl: they state prefasiculation is dead

Osmotic Therapy

Probably a good time to give a dose of hypertonic saline

Induction Agents

Etomidate, Propofol, or Propofol/Ketamine (75%/25%). If Thiopental was still available, it would be on the list as well.

Muscle Relaxants

Rocuronium or Succinylcholine at full dose

Post-Intubation Sedation

Propofol and Fentanyl

Post-Intubation Ventilation

Shoot for 95% saturation, use PEEP only if necessary; but if it is necessary it is safe to use

Increase Respiratory Rate until ETCO2 of 35 mm Hg; then send a blood gas

Other Situations

Basilar Stroke and Stuttering Stroke-lower bp=screwed

Review Article

Has anyone found a good one????

Rich Levitan’s Airway Course

Go here to get the scoop

Now on to the Podcast…

Play

Bibliography

Podcast 128 – Pulmonary Embolism Treatment Options and the PEAC Team with Oren Friedman

pe-show

OrenFriedmanWe now have way too many treatment options for sub-massive and massive pulmonary embolism (PE) patients who aren’t coding in front of you. How do you decide which one is right for your patient? To help answer this question, I am joined today by Oren Friedman, pulmonary critical care doc and one of the members of the Cornell PEAC team.

Cornell Pulmonary Embolism (PE) Advanced Care Team (PEAC), aka the CLOT Team

Oren Friedman MD, Pulm Crit Care; James Horowitz MD, Cardiology; Arash Salemi MD, Cardiac Surgery; Akhilesh Sista MD, Interventional Radiology

You can shoot the team an email: peadvancedcare at gmail dot com

Who Should We Treat?

Wood 2002 PE Mortality Curve

Wood 2002 PE Mortality Curve

30% normotensive patients have RVD; 10% progressed to shock; 5% in hospital mortality(10859287)

The Better Risk Categories for Pulmonary Embolism

  • Well and Stable Sub-Massive
  • High-Risk Sub-Massive
  • Massive

PEITHO Trial

NEJM 2014;370(15):1402

Full dose tenecteplase with concurrent heparin

  • Death or hemodynamic decompensation occurred in 2.6% of the tenecteplase group as compared with 5.6% of the placebo group
  • Extracranial bleeding occurred in 32 patients (6.3%) in the tenecteplase group and 6 patients (1.2%) in the placebo group (P<0.001)
  • Intracranial Bleed 10 patients (2%) in the tenecteplase group and 1 patient (0.2%) in the placebo group (P=0.003)

Also see my bud, Salim Rezaie’s post on PEITHO and Konstantinides’ prior study (12374874)

Ryan Radecki made some great observations in his post on PEITHO

  • The criteria for myocardial injury was a troponin I >0.06 ?g/L or troponin T >0.01 ?g/L.  These may be relatively inclusive thresholds.
  • Not all placebo patients developing hemodynamic collapse received subsequent thrombolysis; likewise, almost half of those who received open-label thrombolysis had no hemodynamic collapse.
  • Half the deaths in the placebo arm were “sudden unexplained” or “other”, compared with bleeding or stroke complications in the thromboysis arm.

TOPCOAT Trial

Jeff Kline’s trial was stopped midway through due to an institution change. Complicated primary endpoint with promising, but unusable results (24484241)

For the scoop on this one see the Bottom Line Review post on TOPCOAT

MOPETT Trial

Half-dose alteplase led to a marked reduction in pulmonary hypertension without sig. complications

Sharifi M et al. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT trial). (J Cardiol 2013; 111: 273)

See this prior EMCrit Wee as well on MOPPETT

Update: This meta-analysis states that the half-dose may be appropriate, effective, and safe (24412030)

Meta-Analysis

Chatterjee et al. have the most current meta-analysis on this topic (JAMA. 2014;311(23):2414-2421)

See the Bottom Line Review post on this study

Nakamura just published another MA this week; see Rory Spiegel’s take on the two here

Is it just in the Oldies?

Markedly lower risk in <75 y/o in PEITHO and <65 in the Meta-Analysis

The Treatment Options

Heparin Alone

tried and true. but even if some degree of resolution of presenting severe symptoms, there is the question of long-term consequences of leaving a large clot burden–namely, loss of exercise tolerance due to chronic pulmonary hypertension

Systemic Thrombolysis

With either full or half-dose alteplase or full-dose tenecteplase

Catheter-Based Intra-Arterial Thombolytic Infusion

Angiography guided placement of pulmonary artery catheters allowing a 24-hour infusion of low dose tPA. (19875060)

A newer therapy is the EKOS catheter. This uses ultrasound to continuously break up the clot during the IA Thrombolysis. Many of us wonder if this is any better than standard catheter-based therapy. (24226805), (23601295) See the PulmCCM Post on the Circulation RCT of EKOS

Interventional Mechanical Clot Disruption

Angiojet

Angiojet

AngioJet-a catheter that breaks up the clot with a high speed jet of saline, heparin, or tPA that then sucks up clot using Bernoulli physics. Very little systemic drug is delivered. Oren’s center doesn’t like the device; other centers use it. This letter is by an adovcate.

Angiovac-Vortex

Angiovac-Vortex

AngioVac-This device uses an ECMO-like system to suck up clot and then return the declotted blood to the venous circulation. It requires huge introducer sheaths. Oren alluded to its main benefit being intra-cavitary or vena cavae clots. Some are billing this as a replacement for embolectomy in many cases.

Surgical Embolectomy

Requires the patient to go on cardiopulmonary bypass and have a sternotomy. Recent experience with surgical embolectomy has had much
better results , much lower mortality than historical, (15867775)

Temporary VA ECMO as a bridge to one of these other therapies

See the EDECMO site for more on this therapy

Oren’s Algorithm

Oren's PE Algorithm

Oren’s PE Algorithm

Oren’s Slide Set

We discussed this topic with Jeff Kline a few years ago in Podcast 51

Fibrinolysis in PE with Jeff Kline

Want to know what to do for the rest of resuscitation for these patients?

We’ll have a podcast soon regarding the management of right ventricular failure, until then see this excellent post by Josh Farkas.

If they go into arrest, give tPA (10.1371/journal.pone.0008323)

As to what dose, who knows? Here is a great post on it. I would give tenecteplase.

expert-commentExpert Commentary on the Podcast

Provocative topic. Like it or not, these [PE Treatment Teams] are here to stay. I managed to get one going at Methodist. How? Well, maybe a little by perseverance, knowing the evidence, showing up for meetings, building alliances. Yeah, sure. But what sold it was when I found out for sure that the main competitor hospital, St. Vincents’ Hospital, was setting up the same program and had treated 18 patients with CDT [catheter-directed therapy] the month before. Then, suddenly attitudes changed. So what will be the main driver? The old ‘reducing practice variability’ line will be the party line. The real driver will be market share.

As Vic Tapson said in ATS two months ago “The practice is racing ahead of the evidence.” While I study lytics, and am a proponent of using them in massive and severe submassive, as your speaker advocates, I have to think like a contrarian for a minute. Funny thing is by reducing variability, we may all be doing the wrong thing instead of just some of us.

The standard lines  from most pulmonologists is “All my submassive PE patients do fine with heparin and warfarin. You guys are putting them at risk because there is no mortality benefit.”

Then the JAMA SR [the Chatterjee one mentioned above] came out 3 weeks ago showing mortality benefit and a huge NNH:NNT ratio for age<65 for survival. A huge shift. Now they say “It still increases bleeding risk…and there is no improvement in quality of life.” So I show them TOPCOAT, and they don’t read it except to see that part of the outcome was a survey, and conclude that they don’t believe in surveys (despite similar surveys being the endpoint for many other lung treatments they use; besides, the SF36 was by far the minority driver of the composite endpoint in TOPCOAT). This is going to be like stroke: a substantial number of physicians with ambiguity intolerance syndrome will say the devil you know is better than the devil you don’t. They see the clot in the lungs as better than the bleed that might happen. There are outspoken emergency physicians who still think lytics are dead wrong for stroke, monkey-fisted that position,  and in some sense have marginalized themselves from the mainstream. I suspect as we go forward, about 40% of the pulmonology community will be shaking their heads saying “what are you guys doing.” But, even if the evidence is mixed, market competition will drive this forward.

At this point, I agree with the speaker, who I believe is a pulmonologist. We should be giving systemic lytics to patients<70 years (more or less) with no contraindications, when the RV that is smashing the LV. Whether we should use catheter-directed therapy (CDT), is to me, the real question at this point. CDT offers the advantage of lower lytic dose, and Ekos  just got FDA clearance to market, and has an army of cardiologists behind them. Curiously, IR guys think Ekos is bogus and prefer CDT. But no trial has compared Ekos or general CDT to systemic lytics, and I doubt any CDT advocates will try such an RCT.

Jeffrey Kline [aka the Man]

comments in brackets are EMCrit’s

Update: Great Post on All of the Above from PulmCrit

Now on to the Podcast…

Play

Bibliography

Podcast 127 – The Oxylator with Jim DuCanto

oxylator

from inter-rescue.de

james-ducantoToday on the show, I talk with my friend Jim DuCanto, MD about the oxylator. Jim is an anesthesiologist extraordinaire with a constant drive to perfect new airway techniques and document them on video along the way.

What is the Oxylator?

A mainly plastic device about the size of your fist with a incredibly quick magnetic valve

It runs on pressurized wall or tank oxygen

Only two main controls, a pressure setting knob and a manual inhalation/automatic mode button

Manual Resuscitator Mode

Press the button and the device will give 30 lpm of inhalation until you let go or it hits the pressure limit you set

Automatic Ventilator Mode

Press in the button and give it a turn and the device switches to automatic ventilation mode. Think of it as a flow-controlled, pressure cycled ventilator in your hand

It gives 30 lpm fixed flow (slow, safe flow) until it hits the user-selectable pressure limit, it then cycles to passive exhalation until it reaches 2-4 cm H20 PEEP and then it begins a new breath

On a patient who is not spontaneously breathing, you can titrate that pressure setting to an inhalation time of 1-2 seconds; this will deliver 500-1000 mls per breath

At those settings, the minute volume will be 10-12 liters/minute

oxylator with mask

from inter-rescue.de

Feedback

The device indicates when you are obstructing by clicking and tells you when there is a mask seal leak by not cycling to the next breath

It Solves the 5 Problems of the BVM

  1. We give too many breaths
  2. Those breaths are at too high a pressure
  3. The breaths are given too rapidly
  4. We get no feedback on whether the breath went in or it was given against an obstructed airway
  5. In a spontaneously breathing patient, the BVM will give variable FiO2s depending on the exhalation port

How we use it

We both use an inline hepa filter, ETCO2 port, and sometimes extension tubing. If you want to use it on a spontaneously breathing patient, OR mask straps are a great addition.

Two models

EMX (25-45 cm H20) and HD (15-30). There are also specialty models for chemical/explosive situations.

Here is Jim’s Overview on the Device

And here are the Slides from a lecture Jim gave at SAM

Here is an example of the use of the Oxylator for an OR Induction

 

Nasal CPAP in Unconscious Patient is More Effective than Full-Face Masks

Crit Care. 2013 Dec 23;17(6):R300.

Oxylator Product Page

This is the EMX Model

Disclaimer and COI

Neither Jim nor I take any money, kickbacks, or incentives from the manufacturer. Both Jim and I have been provided with Oxylators to test and research.

Now on to the Podcast…

Play

Podcast 126 – TTM Trial Right from Niklas Nielsen’s Mouth

coldie

niklas-nielsenIn this episode, I speak with Niklas Nielsen on his thoughts on the TTM trial.

Coverage of the TTM Trial

Kee Polderman’s Editorial

 

Play

Podcast 125 – The New Intra-Arrest from SMACCgold

05intra

Here’s my first lecture from SMACCgold: The New Intra-Arrest. It generated a bit of controversy amongst my critical care friends, so we’ll be discussing various parts in more detail in the coming weeks.

Pitches

 Links and References

VSE Stuff

JAMA 2013;310(3):270

1 mg Epi and 20 IU Vasopressin Q3 minutes for 5 cycles, plus 40mg methylprednisolone for the 1st cycle. Hydrocortisone if in persistent shock

Journal Club Crit Care 2014;18:308

Why Epi and not Phenylephrine

From MH Weil’s Article Above:
Adrenergic agents with predominant a2 effect have been shown to be more effective as vasoconstrictor drugs, presumably because extrajunctional a2-receptors are more accessible to circulating catecholamines than postjunctional a1-receptors. This may explain why adrenergic amines that have predominant a1 actions such as methoxamine (Vasoxyl) and phenylephrine (Neo-Synephrine) are less effective than epinephrine after prolonged cardiac arrest.

Mechanical CPR

LUCAS seems equivalent to excellent manual compressions (from ResusMe)

Cardiac Arrest: To the cath lab with ongoing chest compressions?

Steve Smith has a great post on the topic with a ton of evidence

Consider Dual-Shock for Non-Converting VF/VT

Charles Bruen has a great post with the evidence

Esmolol
Beta-blockade should be considered in all patients with RVF in the ED prior to cessation of resuscitative efforts.

The Slides

Now on to the Podcast…